First myocardial infarction in patients of Indian subcontinent and European origin. Ethnic differences in outcome may be confounded by socioeconomic status.EBSCO_AspBmj British Medical Journal
Therapeutic strategies to antagonize LV remodeling, such as angiotensin-converting enzyme inhibitors and/or beta-blockers, have proven beneficial in treating CHF (4). Despite the value of such medical approaches, progression from myocardial infarction to CHF remains a tremendous burden in terms of ...
it from a -blocker Patients with chronic heart failure (CHF) who have experienced a myocardial infarction (MI) will benefit from a -blockerPatients with chronic heart failure (CHF) who have experienced a myocardial infarction (MI) will benefit from a -blocker...
This study challenges the notion that atherosclerosis, the most common etiology of heart failure in the industrialized world, impairs cardiac function by causing discrete clinical episodes of myocardial infarction or ischemia. We found that increased carotid IMT is associated with reduced regional myocardia...
Posted in Acute Myocardial Infarction, Adaptive Immune Response to Biomaterials and Tissue Repair, Advanced Drug Manufacturing Technology, Amino acids, Apoptosis, Apoptosis, Artificial intelligence applications for cardiology, Artificial...
Myocardial infarction causes significant mortality and morbidity. Timely diagnosis allows clinicians to risk stratify their patients and select appropriate treatment. Biomarkers have been used to assist with timely diagnosis, while an increasing number o
(PC) in men with a history of coronary artery disease (CAD)-induced congestive heart failure (CHF) or myocardial infarction (MI).METHODS:Among 7839 men who received radiation with or without a median of 4 months of HT for PC from 1991 to 2006, 495 (6.3%) had CAD-induced CHF or MI ...
Microcirculatory dysfunction occurs early in cardiovascular disease (CVD) development. Acute myocardial infarction (MI) is a late consequence of CVD. The conjunctival microcirculation is readily-accessible for quantitative assessment and has not previous
Learn more about single-bolus TNKase® (tenecteplase) acute ST elevation myocardial infarction treatment. Please see full Prescribing Information for additional important safety information.
The model included age, diabetes, recent smoking, hypertension, hyperlipidemia, prior myocardial infarction (MI), prior PCI, prior CABG, congestive heart failure (CHF), peripheral vessel disease, end-stage renal disease on current dialysis, major cardiac rhythm/rate disturbance, gender, Killip class...